The influence of the innate immune protein mannose-binding lectin (MBL) on the response of human phagocytes to Neisseria meningitidis was investigated. MBL increased the association of killed meningococci with neutrophils, monocytes, and macrophages by increasing the proportion of cells that recognized bacteria. MBL down-regulated the normal change in expression of the leukocyte adhesion molecules CD11b and CD62L. In an ex vivo model, the addition of MBL to the blood of MBL-deficient donors influenced the production of monocyte-derived inflammatory cytokines. The addition of high concentrations of MBL (16 mg/mL) profoundly decreased the production of interleukin (IL)-6, IL-1b, and tumor necrosis factor-a by monocytes in response to meningococci, whereas lower concentrations enhanced the production of IL-6 and IL-1b. These results suggest that MBL not only is involved in complement activation but also is a potent regulator of inflammatory pathways and, as such, may affect the severity of meningococcal disease.
and may affect functions such as phagocytosis [20, 21] and cytokine production [22] .
The influence of MBL over another important aspect of inflammatory processes, the expression of leukocyte adhesion molecules, has not been addressed. The selectin and b-integrin families of leukocyte adhesion molecules are involved in the rolling and firm attachment of leukocytes to the vascular endothelium [23] . The stimulus of N. meningitidis causes changes in the expression of both leukocyte and endothelial cell adhesion molecules [24] . This process may be important in meningococcal disease, where the attachment of neutrophils to endothelial cells appears to contribute to the vascular damage observed in meningococcal sepsis [24] .
In this study, we investigated the direct effect of MBL on the function of phagocytic cells in response to a serogroup B meningococcus. We used isogenic mutants based on a clinical isolate that differ in capsule expression and LOS structure to determine how such structures may interact with MBL to alter these cellular functions. Using these organisms, we measured the influence of MBL alone on phagocytosis of N. meningitidis and the expression of the leukocyte adhesion molecules CD62L and CD11b. We also assayed the effect of purified MBL on interleukin (IL)-1b, IL-6, and tumor necrosis factor (TNF)-a production by monocytes in response to meningococci, by use of an ex vivo whole-blood model system.
Materials and Methods
Purification of MBL. MBL was purified from human ethanolfractionated plasma paste (donated by C. Dash, Blood Products Laboratory, Elstree, United Kingdom) by a modification of the method of Kilpatrick [25] . After preparing MBL as described, the material was passed through a Pharmacia HR 5/10 column of anti-human IgG, IgM, and IgA (Dako) conjugated to Sepharose (Amersham Pharmacia Biotech), according to the manufacturer's instructions, to positively remove trace immunoglobulin impurities [26] . The MBL concentration was determined by ELISA [7] , and purity was verified by denaturing SDS-PAGE and immunoblotting [26, 27] .
Bacterial strains. The parent organism, N. meningitidis serogroup B (B1940), and its mutants have been described elsewhere [28] . The parent organism was a clinical isolate that possesses a capsule and a fully sialylated LOS of immunotype L3,7,9. The siaD Ϫ mutant is a capsule-negative derivative produced by insertional inactivation of the polysialyltransferase gene; cpsD Ϫ is a deletion mutant in which galE is inactive. It possesses a truncated LOS lacking the outer core that cannot be sialylated. cps Ϫ lacks both a capsule and the outer LOS core as a result of deletion of the entire cps region, which includes galE. All of these organisms are piliated and express the class V outer membrane proteins Opa and Opc, with no detectable differences in the amount or molecular weight of these structures [29] .
Growth and preparation of meningococcal strains. We removed the strains from liquid nitrogen and cultured them overnight at 37ЊC with 6% CO 2 on GC agar (Difco) plates supplemented with Vitox (Oxoid), according to the manufacturer's instructions. Organisms were subcultured at least once before use and were confirmed to be oxidase-positive, gram-negative cocci. Immediately before each experiment, organisms were suspended at 10 8 organisms/mL (measured as an absorbance of 1.0 at 540 nm [A 540 ]) in either veronal-buffered saline supplemented with 5 mM CaCl 2 and 5 mM MgCl 2 (VBS 2ϩ ), for studies on the binding of MBL, or RPMI 1640 medium, for all other experiments.
For fluorescein labeling, organisms (0.5 mL in RPMI 1640 medium without phenol red) at an A 540 of 1 were mixed with an equal volume of fluorescein isothiocyanate (FITC) solution (1 mg/mL in RPMI medium without phenol red) and incubated at 37ЊC for 30 min, as described by Klein et al. [24] . The organisms were spun at 9780 g for 1 min and washed 3 times with 0.5 mL of RPMI medium. Organisms were fixed by the addition of 0.5% wt/vol (final concentration) paraformaldehyde and resuspended in RPMI medium.
To ensure that FITC incubation did not interfere with MBL binding, we used a modification of a method described elsewhere [13] . FITC-labeled organism suspensions (50 mL) were centrifuged before incubation with 25 mL of MBL (1600 ng/mL) for 30 min at 37ЊC, washed, and incubated with 10 mg/mL anti-MBL (clone 131-1; Statens Serum Institut) for 30 min. The organisms were then incubated with 25 mL of a phycoerythrin (PE)-conjugated goat anti-mouse IgG1 antibody (10 mg/mL). By use of flow cytometry, we compared the binding of MBL to the FITC-labeled and unlabeled organisms. The labeling of meningococci with FITC was successful, and the fluorescent marking did not affect MBL binding to the bacteria (data not shown).
Leukocyte separation. Fresh whole blood (15 mL) from healthy laboratory volunteers was placed in 50 U of heparin. Dextran (6% wt/vol) in saline (Amersham Pharmacia Biotech) was mixed 1:10 with the whole blood, and the entire mixture was allowed to stand at room temperature for 1 h to allow the majority of erythrocytes to separate to the bottom of the tube [30] . The upper plasma layer containing the leukocytes was gently removed by aspiration and centrifuged at 200 g for 10 min. The cell pellet was washed with 20 mL of Hanks' balanced salt solution (HBSS; Gibco) without Ca 2ϩ and without Mg 2ϩ and centrifuged as before. The cell pellet was then resuspended in 1 mL of RPMI 1640 medium with glutamate (Gibco) and 0.2% wt/vol bovine serum albumin (BSA; Sigma) or in HBSS with Ca 2ϩ and Mg 2ϩ plus 0.2% wt/vol BSA.
Phagocytosis of N. meningitidis by neutrophils and monocytes.
We modified a flow cytometry method reported elsewhere [31, 32] to determine phagocytosis of organisms. FITC-labeled organisms (50 mL) were incubated with either 25 mL of MBL (2 mg/mL) or buffer (VBS 2ϩ ) alone for 30 min. The organisms were then centrifuged at 9780 g for 1 min and washed once. Leukocytes containing 10 6 neutrophils were mixed with the equivalent of 5 organisms per neutrophil in a total volume of 1 mL, and the suspension was incubated at 37ЊC in 6% CO 2 for 60 min.
Phagocytosis was determined at 60 min by removing 100 mL of the cell suspension and mixing with FACSlyse (Becton Dickinson; 2 mL of 1ϫ solution) for another 10 min at room temperature. For flow cytometry, the cell suspensions were centrifuged at 200 g, and the cell pellet was resuspended in PBS (0.5 mL). Flow cytometry was done on a FACSCalibur (Becton Dickinson), and cell populations were identified by forward and side scatter. Phagocytosis of the FITC-labeled organisms was estimated by measuring the green fluorescence within the gated polymorphonuclear leukocytes (PMNL) or the monocyte population (i.e., the percentage of cells that were associated with bacteria and were either adherent to the cell surface or internalized) [33] . To estimate the proportion of internalized as opposed to adherent organisms, trypan blue was added to the samples to a final concentration of 100 mg/mL, after initial acquisition for 5 min; the samples were then reacquired [31] . At a ratio of 5 organisms to each PMNL, no association of bacteria with lymphocytes was observed without trypan blue. At a higher ratio of organisms to PMNL, some lymphocytes bound bacteria, but this signal was abrogated by trypan blue, which presumably indicated nonspecific association of meningococci with cell surfaces. To ensure that the phagocytosis observed was due to MBL, in certain experiments the lectin preparation used to preincubate the organisms was supplemented with 10 mM EDTA, 25 mM Nacetylglucosamine, or 25 mM galactose.
Association of B1940 cpsD Ϫ with monocyte-derived macrophages (MDMs). Human MDMs were obtained from healthy human volunteers and cultured for 12-14 days in 24-well tissue culture plates on glass coverslips as described elsewhere [34] . Paraformaldehyde-fixed cpsD Ϫ organisms were preincubated with MBL (5 mg/ mL) or buffer (VBS 2ϩ ) alone for 10 min. Organisms were centrifuged and washed once with RPMI 1640 medium containing 10% heat-inactivated fetal calf serum (FCS) before being resuspended in 10% RPMI medium/10% FCS at a concentration of 8 4.8 ϫ 10 cfu/mL. Organism suspensions (250 mL) were added to the MDMs at a median MOI of 120 organisms per cell and were incubated for 30 min at 37ЊC. The supernatant was aspirated, and the cells were fixed with 2% wt/vol paraformaldehyde for 30 min. The cells were washed twice with PBS and incubated with 0.01% vol/vol Triton X-100 (Sigma) and 0.002% wt/vol SDS in PBS containing 85 ng/mL 4,6-diamidino-2-phenylindole dihydrochloride for 12 min at room temperature, as described elsewhere [34] . The cells were washed once with PBS and then with distilled water, and the coverslips were inverted onto mounting medium (Vectashield; Vector Laboratories). Slides were randomized and examined with a Leica DMRB fluorescence microscope, at ϫ100 objective magnification, by laboratory staff who were blind to the sample identity. A minimum of 100 cells were counted, and the number of cells that were positive for organisms and the total number of organisms associated with cells were recorded.
Assay for CD11b and CD62L expression on separated PMNL. Unlabeled cpsD Ϫ (50 mL) organisms were incubated with either 25 mL of MBL (2 mg/mL, near the median MBL concentration for persons of Western European origin) or buffer (VBS 2ϩ ) alone and then centrifuged at 9780 g for 1 min and washed once. PMNL and organisms were mixed as described above, and the cells were incubated at 37ЊC. At 15, 30, and 60 min, the expression of CD11b and CD62L was measured, as described elsewhere [24] , using monoclonal antibodies (MAbs) to CD62L conjugated to PE (Pharmingen) and CD11b conjugated to FITC (Serotec). Changes in CD11b and CD62L expression in the presence of organisms were compared with the changes induced by the addition of 10 ng/ mL Escherichia coli lipopolysaccharide (LPS; Sigma), 10 Ϫ4 M N-FMLP incubated with MBL (2 mg/mL), or buffer alone 10 min before addition to cells. To observe the relationship between CD62L shedding and phagocytosis, in some experiments we used FITC-labeled organisms in place of unlabeled organisms, and the cells were stained for CD62L expression. In each experiment, control samples were included by using labeled antibodies of the appropriate isotype at the same concentrations as the experimental samples.
Assay for intracellular monocyte cytokine production. Whole blood from persons known to have very little or no serum MBL was placed in sodium citrate (final concentration, 0.76% wt/vol), to which brefeldin A (Sigma) was added to a final concentration of 10 mg/mL. Brefeldin A interferes with the export of proteins from the Golgi apparatus and causes the intracellular retention of proteins that would normally be secreted [35] . Blood was aliquoted in 500-mL volumes into polypropylene tubes, and purified MBL was either added or not added at this stage. The blood was then diluted with an equal volume of RPMI 1640 medium containing unlabeled meningococci to a final concentration of organ- 6 5 ϫ 10 isms/mL.
Aliquots of the blood mixture (200 mL) were taken at 3 h and incubated with monoclonal PE-Cy5 anti-CD14 (Serotec) for 30 min at room temperature. The erythrocytes were lysed by the addition of FACSlyse solution (2 mL) for 10 min. Samples were spun at 200 g for 5 min, and the supernatant was decanted and the production of intracellular cytokines assayed as in the manufacturer's (R&D Systems) protocol, using PE-conjugated MAbs to IL-6, TNF-a (Becton Dickinson), or IL-1b (R&D Systems). In brief, cell pellets were washed with HBSS (Gibco) and resuspended in 400 mL of 4% wt/vol paraformaldehyde in PBS for 10 min at room temperature. The samples were centrifuged, and the cell pellet was washed with HBSS before resuspension in 50 mL of saponin buffer (0.1% wt/vol saponin and 0.05% wt/vol NaN 3 in HBSS). We added anti-cytokine antibody (10 mL) to the cell suspension, and the mixture was incubated at room temperature for 40 min in the dark. Samples were then washed twice with saponin buffer before resuspension in HBSS for flow cytometry. Monocytes were selected on the basis of CD14 positivity and size and granularity. At all times, appropriate labeled control antibodies were used to establish negative controls. Positive controls were included in each experiment by using either 20 mg/mL E. coli LPS (Sigma) to stimulate cytokine production or organisms to stimulate excessive 8 5 ϫ 10 phagocytosis. In certain experiments, brefeldin A was not added to the citrated whole blood, and the samples were stained for CD11b and CD62L expression after 15, 30, and 60 min of incubation as described elsewhere [24] . Flow cytometry showed that the concentration of citrate used in this whole-blood model did not influence the binding of MBL [13] .
Effect on monocyte cytokine production of addition of MAbs to C1qR P . An IgG2b MAb to C1qR P (R139; final concentration, 20 mg/mL [36] ) was added to whole citrated blood. This mixture was incubated for 10 min at room temperature before the addition of differing concentrations of MBL and then the immediate addition of cpsD Ϫ organisms. The final concentration of R139 6 5 ϫ 10 for the rest of the experiment was 10 mg/mL. In control experiments, the anti-C1qR P MAb was replaced with an irrelevant MAb. All blood samples contained brefeldin A (10 mg/mL). The intracellular production of IL-6 at 3 h was assayed as described in the previous section and compared to the production of IL-6 in response to cpsD Ϫ organisms alone or with MBL. Statistical analyses. The distribution of data was examined for normality using SPSS software, version 10. Neutrophil data were Downloaded from https://academic.oup.com/jid/article-abstract/184/9/1152/913385 by guest on 12 January 2019 Figure 1 . Top, Neutrophil phagocytosis of isogenic mutants of Neisseria meningitidis preincubated with (ϩ) or without (Ϫ) purified mannose-binding lectin (MBL) for 60 min. Organisms were labeled with fluorescein isothiocyanate (FITC) and were incubated for 30 min with 2 mg/mL MBL or buffer alone. After a wash, organisms were mixed with separated leukocytes at 37ЊC; aliquots were removed after 60 min. Flow cytometry was used to assess neutrophil phagocytosis (percentage of FITC-labeled positive neutrophils). Each point represents mean ‫ע‬ of results from 10 separate experiments (3 donors). * , SEM P ! .05 paired t test. Bottom, Structural differences in capsule and lipooligosaccharide structures are shown as an aid to identification of mutants (described in [13] ).
normally distributed (skewness between Ϫ1 and 1). The data from monocytes and macrophages were not normally distributed and were log 10 transformed to achieve normality. Means and SEMs quoted for this data are the inverse log values of the log-transformed analyses. Differences in the phagocytosis of organisms by PMNL and monocytes at 60 min, in macrophage association at 30 min, and in CD11b and CD62L expression at 30 min with and without MBL were analyzed using paired t tests. Correlations were calculated using the Pearson correlation.
Results

Phagocytosis of meningococci by PMNL and monocytes.
When FITC-labeled organisms alone were incubated with the cell suspension, we observed a low-level time-dependent increase in the percentage of neutrophils staining positive for FITC (increase in the percentage of PMNL that stained positive for FITC). There were small but reproducible differences in phagocytosis in the different organisms; the 2 encapsulated organisms exhibited a higher uptake than the unencapsulated pair (figure 1). After 60 min, an average of 5.7% of PMNL had phagocytosed the parent organism, and 3.3% had phagocytosed cpsD Ϫ organisms. By comparison, only 2.3% had phagocytosed the siaD Ϫ mutant, and 1.8% had phagocytosed the cps Ϫ organism. When organisms were preincubated with MBL, a significant increase in phagocytosis by PMNL was detected at 60 min for the parent ( ) and cpsD Ϫ and cps Ϫ ( ) organisms P ! .02 P ! .05 but not for the siaD Ϫ mutant (figure 1). The level of PMNL phagocytosis with MBL was significantly positively correlated, between different experiments, with phagocytosis without MBL for each mutant at 60 min ( for parent, siaD Ϫ , and cpsD Ϫ ; P ! .05 for cps Ϫ ): As the background phagocytosis at 60 min P ! .01 increased, the level of MBL-mediated phagocytosis increased. The addition of trypan blue did not appear to influence the percentage of PMNL that stained positive for FITC. This indicated that most of the neutrophils associated with organisms had internalized at least 1 bacterium-more than had been observed with live organisms in another study [32] .
The use of a whole leukocyte preparation rather than purified PMNL allowed us to observe phagocytosis by monocytes. Although fewer monocytes were present in the leukocyte suspension, we were usually able to gate this population on size and granularity. There were significant mean increases in phagocytosis of 7.7%, 8.8%, and 9.6% for parent, cps Ϫ , and cpsD Ϫ organisms, respectively ( , t test of log 10 -transformed P ! .05 data). Despite a mean increase in phagocytosis of siaD Ϫ organisms (3.8%), the increase was not significant ( ). P 1 .05 To confirm that the observed increase in phagocytosis was due to MBL, we added EDTA (10 mM), N-acetylglucosamine (25 mM), or galactose (25 mM) to the MBL preparation before it was incubated with the bacteria. The addition of EDTA or N-acetylglucosamine to the MBL preparation before this incubation resulted in a mean reduction in the enhancement of phagocytosis of 70.3% ( , paired t test), whereas the ad-P ! .03 dition of galactose did not inhibit the effect ( ). This P 1 .05 pattern is consistent with the known sugar specificity profile and calcium dependence of MBL [37] .
Effect of MBL on B1940 cpsD Ϫ association with human MDMs. We sought to extend our flow cytometry results by using adherent MDMs and microscopic detection. As shown in figure  2A , the number of organisms associated with 100 macrophages was increased by 28 (mean difference in number of organisms with and without MBL;
). This increase was due to an P ! .02 increase in the percentage of macrophages with attached or engulfed bacteria from 34% without MBL to 42% with MBL ( figure 2B; ). There was no significant increase in the P ! .01 number of organisms associated with each cell in the presence of MBL ( figure 2C ). The addition of 25 mM N-acetylglucosamine to the MBL preparation before its addition to the organisms abrogated the increase in association ( , t tests P 1 .05 of association with organisms incubated with N-acetylglucosamine and with organisms incubated with N-acetylglucosamine and MBL). This inhibition was not observed when 25 mM mannitol, which does not inhibit MBL binding, was used instead of N-acetylglucosamine.
Effect of MBL on neutrophil adhesion molecule expression. Other studies have shown that N. meningitidis is a potent inflammatory stimulus for PMNL, which can be detected by profound changes in the expression of the leukocyte adhesion molecules CD18/CD11b and CD62L [24, 32] . Furthermore, the proinflammatory stimulus of LPS can increase the phagocytosis of N. meningitidis by PMNL [32] . To investigate whether the effect of MBL on phagocytosis could be the result of the influence of the lectin on the inflammatory response of these cells, we examined the change in adhesion molecule expression over time in response to the cpsD Ϫ mutant, which was previously shown to bind MBL avidly [13] .
The incubation of this mutant with separated leukocytes resulted in a time-dependent increase in the expression of the b2 integrin CD11b and a loss in the expression of the selectin CD62L ( figure 3A-3D ). When the organism was preincubated with MBL at 2 mg/mL (near the mean concentration for persons of Western European origin), a reduction in these changes over the course of time was observed that was significant at 30 min (paired t test). In experiments with FITC-labeled organisms and staining of neutrophils for CD62L expression, no correlation between phagocytosis and loss of CD62L was observed in the absence of MBL, as was described elsewhere [32] . This finding was not altered by preincubation of the organisms with the lectin.
To determine whether this effect could still be observed in the presence of other serum components, a similar experiment was performed, using citrated whole blood rather than separated PMNL. Inhibition of adhesion molecule expression was again observed (results not shown), but, in these experiments, a higher dose of MBL (8 mg/mL) was required. The loss in CD62L and the increase in CD11b expression appeared to be accelerated in comparison with that in separated cells; the inhibitory effect of MBL was seen after incubation for 15 min. When MBL was used at concentrations !8 mg/mL, there was no apparent change in adhesion molecule expression.
Effect of MBL on monocyte intracellular cytokine production. After the addition of cpsD Ϫ organisms to whole blood, 6 5 ϫ 10 we detected intracellular production of IL-1b, IL-6, and TNFa by monocytes at 3 h. With the addition of MBL (4 mg/mL) to whole blood, there was a reduction in the production of IL-6 in response to the cpsD Ϫ mutant that was not apparent when LPS was used instead of organisms to stimulate the monocytes (figure 4). The influence of MBL on TNF-a and IL-1b production differed markedly from the effect on IL-6; with 4 mg/ mL MBL, there was little if any effect on TNF-a production, but IL-1b production was increased (figure 4).
To further explore this effect, MBL was added at differing concentrations to whole blood, and the effect on cytokine production in response to the cpsD Ϫ mutant was measured (figure 5). MBL influenced the production of all 3 cytokines, but the patterns of modulation differed. Although the addition of MBL at low doses (up to ∼2 mg/mL) caused a small increase in IL-6 and TNF-a, the increase in IL-1b was seen over a wider range of MBL concentrations (р4 mg/mL). At high concentrations (16 mg/mL MBL), the production of all 3 cytokines was suppressed.
The pattern was not restricted to organisms exhibiting high levels of MBL binding, and the modulation of all 3 cytokines by the parent organism was similar to that observed with the cpsD Ϫ organism at 4 mg/mL MBL ( figure 6 ). The representative plots in figure 6A show that IL-1b production was enhanced, whereas IL-6 production was reduced (data are summarized in figure 6B ). In comparison, the influence on TNF-a production was much less pronounced, with a slight reduction in cytokine expression when lectin was used at a final concentration of 4 mg/mL ( figure 6B) .
Effect of anti-C1qR P antibodies on MBL modulation of monocyte cytokine production. To investigate the mechanism by which MBL could reduce the cytokine response to meningococci, antibodies to the phagocytic C1q receptor, C1qR P , were added to samples of blood from MBL-deficient persons that were then challenged with meningococci with or without addition of exogenous MBL. In blood with no exogenous MBL, the addition of the R139 antibody and then of meningococci led to a marginally reduced level of IL-6 production (mean reduction, 5.1% in 5 experiments). This reduction did not occur when a control mouse antibody was substituted for R139; however, when MBL was added to the blood, the addition of R139 failed to modulate IL-6 production (figure 7).
Discussion
MBL acts as a direct opsonin for the gram-negative bacterium Salmonella montevideo [21] and other pathogens [38, 39] . In the present study, MBL alone was sufficient to stimulate an increase in association and phagocytosis. This appeared to occur via an increase in the percentage of cells associated with organisms rather than by an increase in the number of organisms bound to each cell, a finding similar to that of another report, on Mycobacterium avium uptake by neutrophils [39] . However, the enhancement we observed did not appear to be a simple function of the amount of MBL bound. By use of isogenic mutants of N. meningitidis, we observed that the comparative increase in neutrophil phagocytosis could be ranked as follows: cpsD Ϫ mutant 1 parent organism 11 cps Ϫ mutant. We reported elsewhere that MBL was bound most strongly by mutants with truncated LOS structures (cpsD Ϫ and cps Ϫ ) [13] . Small amounts were bound by the siaD Ϫ mutant, and very little or no MBL was bound by the parent organism [13] . If MBL was acting as a direct opsonin, our earlier observations would lead us to predict that phagocytosis would be greatest for the cps Ϫ mutant, followed by the cpsD Ϫ and siaD Ϫ mutants, and then by the parent organism. Flow cytometry has finite detection limits [14, 40] , and our current results suggest that MBL is likely bound by the parent organisms at levels below such detection limits. This binding level did not lead to a detectable increase in complement activation, despite the amplification inherent in this system [13] .
The increase in neutrophil phagocytosis by MBL, although comparable to that seen in other studies that involved different organisms [39] , appears unlikely to contribute enough direct opsonic activity to be significant in meningococcal pathogenesis. In the presence of a replete complement system, the increased deposition of C3 fragments that would be expected to occur after the activation of complement by MBL is probably of greater importance in the opsonization and phagocytosis of meningococci in the vascular system [10, 41] . The use of adherent macrophages was instructive, because it showed that, for this cell type, there was a marked increase in the number of organisms per 100 cells in the presence of MBL. This increase was due to an enhancement of the percentage of macrophages binding organisms, as we had observed with the neutrophils and monocytes, and not to an increase in the number of organisms per cell. This is similar to the results of a report by Polotsky et al. [39] , which showed that the percentage of neutrophils taking up M. avium was increased by MBL but that the number of organisms per cell was unchanged. Resident mucosal phagocytes such as macrophages likely provide an important defense against meningococcal invasion of the nasopharynx. Meningococci are observed deep within resected tonsillar tissue of persons colonized by N. meningitidis [42] and are phagocytosed by mononuclear phagocytes during experimental colonization of human nasopharyngeal mucosa [43] .
We suggest 2 alternative modes of operation for MBL, from the results of our experiments. The first is that MBL may act to enhance nonopsonic phagocytosis. There was a correlation between the enhancement of phagocytosis and the amount of nonopsonic phagocytosis in the absence of MBL. Nonopsonic phagocytosis of meningococci by PMNL has not been extensively studied, but there appears to be a complex relationship between the expression of LOS sialic acid, capsule, pilli, and opacity proteins [44] [45] [46] . Encapsulation itself may not necessarily decrease internalization of meningococci by phagocytic cells [34] . The results from this study may support other reports that suggest that MBL can potentiate other phagocytic pathways [20, 47] . A second possibility is that MBL could alter Influence of antibodies to C1qR P on interleukin (IL)-6 modulation by mannose-binding lectin (MBL). Monoclonal antibody (R139) to phagocytic C1q/MBL receptor, C1qR P [36] , was added to whole blood 10 min before addition of buffer or of different concentrations of MBL known to cause inhibition or stimulation of IL-6 production and Neisseria meningitidis B1940 cpsD Ϫ . Results are mean in cytokine expression in whole blood with and without change ‫ע‬ SEM MBL or anti-C1qR P for 3 separate experiments (1 donor). Light columns, R139, 0 mg/mL; dark columns, R129, 10 mg/mL. phagocytosis through modulation of the inflammatory response. Phagocytosis of meningococci by neutrophils appears to be up-regulated via the powerful inflammatory stimulus of LPS and can be blocked by a specific inhibitor of LPS function, recombinant bactericidal-permeability-increasing protein [32] . Therefore, we investigated whether MBL could influence the inflammatory consequences of leukocyte-meningococcal interactions independently of phagocytosis.
Neutrophils stimulated with N. meningitidis rapidly lose the expression of CD62L and up-regulate expression of CD11b [24] , an effect not limited to the cells that phagocytose meningococci [32] . When organisms were preincubated with MBL and then mixed with purified leukocytes, a decrease in the change of CD62L and CD11b expression was observed in the entire neutrophil population at 30 min. This occurred when organisms were introduced to PMNL in the absence of serum and in whole blood, but, in the latter case, a supraphysiologic concentration of the lectin (8 mg/mL) was required. Such a concentration would probably only occur in association with a significant acute-phase response [48] . This suggests that MBL can modulate adhesion molecule expression in both purified and complex assays; however, the relative amounts required may differ, perhaps because of the contribution of other factors (such as complement activation), although that contribution is reduced in this ex vivo blood model [49] .
The initiation of changes in leukocyte adhesion molecules is one of the first steps in inflammation, allowing inflammatory cells such as PMNL and monocytes to migrate from the vascular system. Neutrophils appear to mediate vascular endothelial damage in response to meningococci [24] , which is an important cause of shock in patients with meningococcal disease. This process requires that neutrophils adhere to the endothelial cells through adhesion molecules and ligands present on both cells. Changes in adhesion molecule expression lead to changes in neutrophil adhesion to vascular endothelial cells [50] , and therefore the potential for MBL to delay this process or to regulate the underlying mechanisms could have profound implications for severity of disease.
We also observed that MBL had an effect on cytokine responses to N. meningitidis. When increasing concentrations of MBL were added to whole blood, there was an initial increase in cytokine production (most marked for IL-1b), with progressively reduced levels of inflammatory cytokines at higher lectin concentrations. The concentration at which production of all 3 cytokines was suppressed appeared to correlate with the suppression in the change in adhesion molecule expression (8 mg/mL). Organisms with different binding capacities for MBL (cpsD Ϫ and the parent organism) showed similar modulations in cytokine production.
Our results support those of studies that showed that MBL regulates inflammatory cytokine release by monocytes [22, 51, 52] . None of these reports identified a specific receptor for the effects observed, although one study indicated that a C1q receptor might be involved [22] . We examined whether the regulation of cytokine production was due to an interaction with C1qR P , the putative C1q/MBL receptor that mediates phagocytosis [20] . When a blocking MAb specific for C1qR P was used, no evidence of modulation of cytokine production by MBL was seen. This may indicate some indirect action of MBL or an interaction with an alternative receptor or binding protein such as CR1 [47] .
Although the mechanisms for the results described have not been elucidated, the differential effects of MBL on the 3 cytokines examined may provide some clues. It is clear that many of the inflammatory consequences of bacteria-host cell interactions are mediated through human Toll-like receptors (hTLRs), with hTLR4 acting as the principal mediator of LPS signaling [53] . However, meningococci can stimulate cytokine production through hTLR2 in the absence of the endotoxin moiety [54, 55] . Our results are consistent with MBL acting to modulate 1 or more of these innate hTLR pathways. Perhaps of greatest interest is that, at least for hTLR2, phagocytic receptors, internalized bacteria, and TLRs in the phagosome may all be involved in triggering the inflammatory response to specific microorganisms [56] . Further studies are required to examine these mechanisms in more detail.
One report [9] suggested that, although genetic deficiency of MBL was related to an increased risk of meningococcal infection, the severity of the disease in these individuals was reduced. This was supported by a family study [57] . Our results suggest that even minimal amounts of bound MBL are sufficient to influence inflammatory cell function. This may be pertinent to meningococcal disease, in which both activation of inflammatory processes and the relative proportions of pro-and antiinflammatory cytokines may be critical to the outcome of the disease [15, 17] .
MBL is an acute-phase protein.
After an inflammatory stimulus, levels increase to as much as 2-3 times the basal concentration [48, 58] . Our findings that the influence of MBL on inflammatory pathways are dose dependent indicate that MBL may act differently as disease progresses. High levels of MBL, determined either genetically or by an acute-phase response, may lead to greater C3 cleavage and subsequent complement activation and phagocytosis, with a diminished production of proinflammatory cytokines. In contrast, lower levels of MBL may be less effective in activating complement but could act to enhance proinflammatory cytokines, with MBL deficiency leading to lower complement activation and lower cytokine release. The pluripotent nature of MBL could act to influence both the susceptibility and the severity of meningococcal disease. Further studies are needed to determine how MBL determines the balance between pro-and anti-inflammatory cytokines and how it influences disease severity.
In conclusion, our findings show that MBL alone can enhance the phagocytosis of serogroup B meningococci. We postulate that this may occur through the enhancement of nonopsonic processes or via regulation of the activation of phagocytic cells. Such processes do not exclude the possibility that MBL may also function as a direct opsonin [21] that can interact with 1 or more collectin receptors [20, 47, 59] . We demonstrate that MBL exerts complex control over multiple inflammatory responses on such cells, both in serum-free conditions and in the complex environment of whole blood. On the basis of observations about complement activation and killing of organisms with truncated or nonsialylated LOS that we have published elsewhere, we propose that MBL may be able to promote the killing of meningococci by increased complement activation, while limiting or regulating the ensuing inflammatory response. The genetically determined wide variation in MBL levels observed within most human populations [7, [60] [61] [62] may in part explain the variation in the innate response to this organism.
